Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-25-108325
Filing Date
2025-08-13
Accepted
2025-08-13 20:55:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2955
  Complete submission text file 0000950170-25-108325.txt   5306
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Subject) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 144 | Act: 33 | File No.: 001-38042 | Film No.: 251213806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)